No results found.

Screeners (33,980)

Signal Glossary

DTL Breach Warning
Price has pushed through the Demand Threshold Line (those orange bars). It flags price vulnerability at/through that boundary for the current week.
Smart Money Buy
A โ€œsmart moneyโ€ star printed on the chart. It marks concentrated, high-quality buying activity often seen ahead of stronger moves. (We only log it when the star appears.)
Investor Buy
An โ€œinvestor buyโ€ star printed on the chart. It reflects broader, more general momentum by investors. (Again, only logged when the star appears.)
Accumulation
A green bar (often within a negative market cycle). Each green bar signals steady, systematic buying/absorbing of supply.
Distribution
The counterpart to accumulation. It marks persistent selling/handing off of shares - supply is dominating and pressure is to the downside.
Ribbon Change
The ribbon flips color (red โ†” green). We log the first bar of a new segment, which signals a regime shift in the underlying indicator.
Threshold Breach (Buy)
The composite indicator crosses down through the dynamic Bottom threshold. Itโ€™s a โ€œbuy-sideโ€ extreme that often precedes an upward move.
Threshold Breach (Sell)
The composite indicator crosses up through the dynamic Top threshold. Itโ€™s a โ€œsell-sideโ€ extreme that often precedes a downward move.
Baseline Crossover
The tracked metric crosses its baseline (typically zero). Crossing up suggests improving conditions; crossing down suggests deterioration.
Demand โˆ’1 Crossover
Price crosses up through the โ€œโˆ’1 demandโ€ reference level. It signals a possible early improvement in demand conditions after a weak phase.
Valuation Change
A change in our valuation classification (e.g., from overvalued to fairly valued). It captures a material update to the valuation state for screening.
Info Update
A notable informational event (e.g., earnings/guidance/corporate update) that we tag for the screener so you can filter around fresh developments.
ML Turned Positive
The Magic Line (smoothed activity) crosses above zero and turns positive. It indicates a shift toward constructive momentum/pressure.
ML Turned Negative
The Magic Line crosses below zero and turns negative. It indicates a shift toward weakening momentum/pressure.

Nasdaq

(NASDAQ)
AKAM
Akamai Technologies, Inc.
?
Accumulation ?
C3 F2 O3 R1
?
Fairly Valued
Target: 81.15 ?
ALT
Altimmune, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ARTL
Artelo Biosciences, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BMRN
BioMarin Pharmaceutical Inc.
?
Accumulation ?
C2 F1 O3 R3
?
Moderately Undervalued
Target: 57.20 ?
BRAG
Bragg Gaming Group Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CRDF
Cardiff Oncology, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CTRM
Castor Maritime Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
DMRC
Digimarc Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
DOX
Amdocs Limited
?
Accumulation ?
C2 F1 O2 R3
?
Deeply Undervalued
Target: 120.35 ?
ENPH
Enphase Energy, Inc.
?
Accumulation ?
C3 F2 O3 R1
?
Extremely Undervalued
Positive ?
EOLS
Evolus, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
FIVN
Five9, Inc.
?
Accumulation ?
?
Extremely Undervalued
Positive ?
GDEN
Golden Entertainment, Inc.
?
Accumulation ?
C1 F1 O1 R1
?
Significantly Overvalued
Target: 18.20 ?
GERN
Geron Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
HPK
HighPeak Energy, Inc.
?
Accumulation ?
C1 F1 O1 R1
?
Extremely Undervalued
Positive ?
IBRX
ImmunityBio, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
IOVA
Iovance Biotherapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
NOVT
Novanta Inc.
?
Accumulation ?
C1 F1 O2 R1
?
Significantly Overvalued
Target: 75.80 ?
NRIX
Nurix Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
NSIT
Insight Enterprises, Inc.
?
Accumulation ?
C1 O2 R1
?
Extremely Undervalued
Positive ?
PRTH
Priority Technology Holdings, Inc.
?
Accumulation ?
C3 F2 O1 R1
?
Significantly Overvalued
Target: 3.31 ?
PUBM
PubMatic, Inc.
?
Accumulation ?
C1 F1 O2 R1
?
Deeply Overvalued
Negative ?
QNST
QuinStreet, Inc.
?
Accumulation ?
C3 F1 O3 R3
?
Deeply Undervalued
Positive ?
RIME
Algorhythm Holdings, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
RPD
Rapid7, Inc.
?
Accumulation ?
?
Extremely Undervalued
Positive ?
SDGR
Schrรถdinger, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
SPT
Sprout Social, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
VERX
Vertex, Inc.
?
Accumulation ?
C1 F1 O2 R1
?
Significantly Overvalued
Target: 13.60 ?
XAIR
Beyond Air, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ACTU
Actuate Therapeutics, Inc. Common stock
?
Accumulation ?
No valuation data
?
โ€”
โ€”
AGRI
AgriFORCE Growing Systems Ltd.
?
Accumulation ?
C2 F1 R1
?
Moderately Overvalued
Target: 1.67 ?
AIRO
AIRO Group Holdings, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ALZN
Alzamend Neuro, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ANNA
AleAnna, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ASNS
Actelis Networks, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BGL
Blue Gold Limited
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BIRD
Allbirds, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BRZE
Braze, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CBLL
โ€”
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CERO
CERo Therapeutics Holdings, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
DSP
Viant Technology Inc.
?
Accumulation ?
C3 F2 O3 R2
?
Deeply Overvalued
Negative ?
FIP
FTAI Infrastructure Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
HNST
The Honest Company, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
LFST
LifeStance Health Group, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
LINE
Lineage, Inc.
?
Accumulation ?
C1 F1 O1 R1
?
Deeply Overvalued
Negative ?
LNZA
LanzaTech Global, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
OPAL
OPAL Fuels Inc.
?
Accumulation ?
R1
?
Extremely Undervalued
Positive ?
TLX
Telix Pharmaceuticals Limited
?
Accumulation ?
C2 F1 O2 R1
?
Extremely Undervalued
Positive ?
UDMY
Udemy, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
WEST
Westrock Coffee Company
?
Accumulation ?
C1 F1 R1
?
Moderately Overvalued
Target: 3.60 ?